Coloplast A/S (CLPBY)
OTC: CLPBY
· Real-Time Price · USD
9.60
0.07 (0.72%)
At close: Jun 06, 2025, 3:58 PM
Coloplast A/S Cash Flow Statement
Financials in DKK. Fiscal
year is
October - September.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Net Income | 1.81B | 1.84B | 1.31B | 1.27B | 1.77B | 1.81B | 1.65B | 1.71B | 1.65B | 1.76B | 1.78B | 1.74B | 1.3B | 1.61B | 1.65B | 1.59B | 1.38B | 1.54B |
Depreciation & Amortization | 344M | 328M | 335M | 328M | 319M | 308M | 277M | 263M | 268M | 261M | 259M | 260M | 236M | 175M | 191M | 209M | 190M | 202M |
Stock-Based Compensation | n/a | n/a | n/a | -1M | 3M | -1M | 56M | -1M | n/a | n/a | 34M | 13M | -1M | 3M | 51M | 3M | 1M | -2M |
Other Working Capital | -751M | -4M | -150M | 88M | -16M | -77M | 32M | 74M | -68M | -27M | 246M | -69M | -951M | 106M | 398M | 116M | -679M | 251M |
Other Non-Cash Items | -322M | -331M | 175M | 1.24B | -3.82B | -215M | -462M | -783M | -442M | -1.03B | -209M | -348M | -142M | -722M | -233M | -468M | -109M | -772M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 1M | -56M | 1M | n/a | n/a | -34M | -13M | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.09B | 172M | 224M | -303M | -841M | -112M | 421M | -25M | -788M | -501M | 312M | -75M | -1.15B | 63M | 346M | 44M | -711M | 246M |
Operating Cash Flow | 742M | 2.01B | 2.05B | 1.49B | -2.56B | 1.79B | 1.88B | 1.17B | 689M | 487M | 2.14B | 1.58B | 250M | 1.13B | 1.95B | 1.38B | 747M | 1.21B |
Capital Expenditures | -310M | -308M | -392M | -352M | -274M | -276M | -384M | -291M | -291M | -275M | -402M | -263M | -269M | -201M | -286M | -221M | -229M | -1.23B |
Cash Acquisitions | n/a | 192M | n/a | 2M | 8M | 8M | -7.92B | 1M | 2M | n/a | 1M | 3M | 7M | n/a | n/a | -38M | -58M | n/a |
Purchase of Investments | n/a | -21M | n/a | n/a | -13M | -8M | n/a | -1M | -17M | n/a | n/a | -2M | n/a | n/a | -14M | 25M | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | 8M | n/a | 16M | 200M | n/a | n/a | -1M | n/a | n/a | -1M | 30M | n/a | 1M |
Other Investing Acitivies | -29M | -26M | -40M | -42M | -44M | 1M | 5M | 1M | 128M | -77M | -93M | 1M | -10.63B | -26M | -14M | 7M | -58M | 3M |
Investing Cash Flow | -309M | -133M | -432M | -350M | -287M | -267M | -8.3B | -274M | -106M | -275M | -401M | -262M | -10.89B | -201M | -301M | -197M | -287M | -1.23B |
Debt Repayment | -521M | 2.11B | -1.87B | 42M | 2.72B | -62M | -2.57B | 441M | -572M | -66M | -1.84B | -67M | 11.02B | 2.28B | -1.52B | 182M | -520M | 2.91B |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -48M | -136M | -435M | n/a | -158M | -281M | -61M | n/a |
Dividend Paid | n/a | -3.83B | n/a | -1.13B | n/a | -3.6B | n/a | -1.06B | n/a | -3.19B | n/a | -1.06B | n/a | -2.98B | n/a | -1.06B | n/a | -2.77B |
Other Financial Acitivies | -76M | -67M | -77M | -64M | -65M | 2.08B | -64M | -61M | -53M | 3.32B | -71M | 44M | -58M | -49M | -55M | -48M | -50M | -49M |
Financial Cash Flow | -598M | -1.76B | -1.7B | -1.15B | 2.81B | -1.48B | 6.47B | -655M | -623M | 74M | -1.96B | -1.22B | 10.52B | -745M | -1.66B | -1.15B | -494M | 125M |
Net Cash Flow | -177M | 118M | -99M | -2M | -27M | 5M | 56M | 227M | -43M | 257M | -220M | 117M | -125M | 194M | 1M | 29M | -17M | 112M |
Free Cash Flow | 432M | 1.7B | 1.66B | 1.14B | -2.83B | 1.51B | 1.5B | 878M | 398M | 212M | 1.74B | 1.31B | -19M | 930M | 1.67B | 1.16B | 518M | -18M |